Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Unlocking human potential with breakthrough mammary biotechnology.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Reduced develops natural flavor enhancers from upcycled produce.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Chromologics develops innovative natural food colorants.
Booster Therapeutics is a biotech company that offers regulation of cellular homeostasis, as well as develops medicines for aging diseases.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
EnergyRe is at the center of the clean energy future.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 22 different industry categories.
Among tracked funding rounds, Praxis Precision Medicines received $575.0M in a Post Ipo Equity round. Novo Holdings's total known invested capital is $18.6B.
Novo Holdings's average investment size is $86.1M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Engimmune Therapeutics, Precirix, Freeline, Rondo Therapeutics, 21st.BIO. These companies were founded in 2020 or later.